A CLINICOPATHOLOGICAL STUDY OF 10 PATIENTS WITH RECURRENT UNEXPLAINED FLUSHING

被引:17
作者
FRIEDMAN, BS [1 ]
GERMANO, P [1 ]
MILETTI, J [1 ]
METCALFE, DD [1 ]
机构
[1] NIAID,CLIN INVEST LAB,MAST CELL PHYSIOL SECT,BETHESDA,MD 20892
关键词
D O I
10.1016/0091-6749(94)90232-1
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
We describe the clinicopathologic features of 10 patients with recurrent unexplained flushing. These patients were referred to the National Institutes of Health with a diagnosis of mastocytosis or idiopathic anaphylaxis. Both diagnoses were eliminated after evaluation. Patients reported attack of flushing lasting 15 minutes to 2 days and associated with such symptoms as anxiety, chest tightness, paresthesia, slurred speech, weakness, and pruritus. Abdominal pain was a constant feature, often associated with cramping and an increase in stool frequency. Attack witnessed by physicians consisted of an exaggerated blush response of the face and upper part of the chest, and were sometimes associated with tachycardia, mild hypertension, and tachypnea. Hives, angioedema, wheezing, and hypotension were not observed. Routine laboratory studies and 5-hydroxyindoleacetic acid, vanillylmandelic acid, and plasma histamine levels were normal. Plasma histamine levels did not elevate during attacks. When performed, results of bone marrow examinations skin biopsies, and bone scans were normal. Psychiatric examinations frequently revealed somatization disorders. Patients had often been prescribed a wide variety of medications including antihistamines, nonsteroidal anti-inflammatory drugs, and steroids, with little or no benefit Despite the benign nature of the clinical and laboratory findings, patients had undergone repeated, often invasive, examinations for several years. Whether such patients have a prominent flush response exaggerated through a somatization disorder or a relatively benign flushing disorder associated with putative mediator release remains to be determined. Recognition of this category of patients with unexplained flushing will avoid subjecting such patients to unwarranted repeated examinations, procedures, and inappropriate therapy.
引用
收藏
页码:53 / 60
页数:8
相关论文
共 20 条
[1]   DISTINGUISHING FEATURES OF IDIOPATHIC FLUSHING AND CARCINOID-SYNDROME [J].
ALDRICH, LB ;
MOATTARI, AR ;
VINIK, AI .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (12) :2614-2618
[2]   MEASUREMENT OF PLASMA HISTAMINE - DESCRIPTION OF AN IMPROVED METHOD AND NORMAL VALUES [J].
DYER, J ;
WARREN, K ;
MERLIN, S ;
METCALFE, DD ;
KALINER, M .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1982, 70 (02) :82-87
[3]  
FRIEDMAN BS, 1989, AM J MED, V87, P649
[4]   A SURVEY OF THE NUMBER AND DISTRIBUTION OF MAST-CELLS IN THE SKIN OF PATIENTS WITH MAST-CELL DISORDERS [J].
GARRIGA, MM ;
FRIEDMAN, MM ;
METCALFE, DD .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 82 (03) :425-432
[5]   WHAT IS THE CAUSE OF THE CARCINOID FLUSH [J].
GRAHAMESMITH, DG .
GUT, 1987, 28 (11) :1413-1416
[6]   BRADYKININ IN CARCINOID-SYNDROME [J].
GUSTAFSEN, J ;
BOESBY, S ;
NIELSEN, F ;
GIESE, J .
GUT, 1987, 28 (11) :1417-1419
[7]  
MEDLIN IM, 1980, J CLIN GASTROENTEROL, V2, P349
[8]  
MEGGS WJ, 1984, NEW ENGL J MED, V78, P9
[9]   THE FLUSHING PATIENT [J].
MOONEY, E .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1985, 24 (09) :549-554
[10]   RELEASE OF MARKEDLY INCREASED QUANTITIES OF PROSTAGLANDIN-D2 INVIVO IN HUMANS FOLLOWING THE ADMINISTRATION OF NICOTINIC-ACID [J].
MORROW, JD ;
PARSONS, WG ;
ROBERTS, LJ .
PROSTAGLANDINS, 1989, 38 (02) :263-274